Browsing Tag

Partnering

580 posts

Roche, Sarepta Sign $2.85-Bn Licensing Deal for Gene Therapy
By

By
Roche has signed a licensing agreement, worth up to $2.85 billion ($1.15 billion upfront), with Sarepta Therapeutics, a Cambridge, Massachusetts-based biopharmaceutical company, to provide Roche with exclusive commercial rights outside…

Sumitomo Dainippon, Roivant Sciences Complete $3-Bn Strategic Alliance
By

By
Sumitomo Dainippon Pharma and Roivant Sciences, a technology-enabled healthcare company, have completed a deal to form their previously announced strategic alliance and have formed a new company, Sumitovant Biopharma, in…

Amgen Acquires Equity Stake in BeiGene for $2.8 Bn; Forms Strategic Pact in China
By

By
Amgen has acquired an equity stake in BeiGene, a Beijing-based pharma company, for $2.8 billion and formed a strategic oncology-drug pact with BeiGene in China and globally. The companies had…

Global Pharma Briefs: News from Europe, Asia and the US
By

By
A roundup of developments and latest news from Germany (AstraZeneca, Cheplapharm), India (Sun Pharmaceuticals), United States (Amneal, Eli Lilly and Company, Sanofi). Germany AstraZeneca Completes Agreement with Cheplapharm for Seroquel…

AbbVie and Scripps Research to Collaborate for Drug Development
By

By
AbbVie has formed a collaboration to develop new therapies for a range of diseases in therapeutic areas of oncology, immunology, neurology and fibrosis with Scripps Research, a non-profit biomedical research…

Amgen Partners for Outcomes-Based Reimbursement for Blockbuster Enbrel
By

By
Amgen has formed an outcomes-based contract with Abarca, a pharmacy benefit manager (PBM), for Amgen’s blockbuster, Enbrel (etanercept), an anti-inflammatory drug. Under the agreement, Amgen will issue rebates to Abarca’s…

AbbVie, Harpoon Therapeutics in $820-Million Deal for Immunotherapies
By

By
AbbVie has signed two agreements with Harpoon Therapeutics, a clinical-stage immunotherapy company, in deals worth up to $820 million involving the discovery and development of T cell engagers targeting both…

Global Pharma Briefs: News from Europe, Asia and the US
By

By
A roundup of developments and latest news from China (Dollar Tree), Germany (Bayer), India (Zydus Cadila), and the United States (Entera Bio, Torrent Pharma). China FDA Issues Warning Letter to…

Novo Nordisk, Dicerna in $675-M-Plus Deal for RNAi Therapies
By

By
Novo Nordisk and Dicerna Pharmaceuticals, a biopharmaceutical company specializing in ribonucleic acid interference (RNAi) therapies, have formed a collaboration to discover and develop therapies for treating liver-related cardio-metabolic diseases, in…

AstraZeneca To Create New R&D and AI Centers, $1-Bn Joint Fund in China
By

By
AstraZeneca has announced three large-scale initiatives in China to advance global research and development (R&D) for innovative new medicines. The company is creating a new global R&D center and an…